Rockwell Medical, Inc. (DE) Common Stock (RMTI) is a publicly traded Healthcare sector company. As of May 21, 2026, RMTI trades at $0.82 with a market cap of $30.84M and a P/E ratio of -5.45. RMTI moved +2.23% today. Year to date, RMTI is -17.00%; over the trailing twelve months it is -23.36%. Its 52-week range spans $0.74 to $5.15. Analyst consensus is buy with an average price target of $3.00. Rallies surfaces RMTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rockwell Medical Targets Q4 Profitability in Updated 2026 Guidance with Q1 Results: Rockwell Medical reported its first quarter 2026 financials and issued updated full-year guidance targeting adjusted EBITDA profitability by Q4 2026. The company emphasized operational cost reductions and cash flow improvements to support its profitability objective.
| Metric | Value |
|---|---|
| Price | $0.82 |
| Market Cap | $30.84M |
| P/E Ratio | -5.45 |
| EPS | $-0.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.15 |
| 52-Week Low | $0.74 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $67.68M |
| Net Income | $-5.40M |
| Gross Margin | 17.07% |
2 analysts cover RMTI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.00.